- Citations, last 5 years
- 330.1k
- Works, last 5 years
- 46.2k
- h-index
- 1,114
- Scientists listed
- 3 440
- Grants since 2016
- 4 931
Grants received
1989–2022 · research · R37
Role of CREM in Amebic Colitis and Inflammatory Bowel Disease
William A Petri · University of Virginia · funded by National Institutes of Health
1989–2027 · research · R37
Role of CREM in Amebic Colitis and Inflammatory Bowel Disease
William A Petri · University of Virginia · funded by National Institutes of Health
1988–2020 · research · R01
Growth and Regeneration in the Inner Ear
Jeffrey T Corwin · University of Virginia · funded by National Institutes of Health
1987–2024 · research · R01
Protein Sequencing by Tandem Mass Spectrometry
Donald F Hunt · University of Virginia · funded by National Institutes of Health
1987–2024 · research · R01
Protein Sequencing by Tandem Mass Spectrometry
Donald F Hunt · University of Virginia · funded by National Institutes of Health
1987–2024 · research · R01
Protein Sequencing by Tandem Mass Spectrometry
Donald F Hunt · University of Virginia · funded by National Institutes of Health
1987–2025 · research · R01
Protein Sequencing by Tandem Mass Spectrometry
Donald F Hunt · University of Virginia · funded by National Institutes of Health
1986–2023 · research · R01
Ontogeny of Central Neural Taste Responses
David L Hill · University of Virginia · funded by National Institutes of Health
1986–2023 · research · R01
Ontogeny of Central Neural Taste Responses
David L Hill · University of Virginia · funded by National Institutes of Health
1986–2023 · research · R01
Ontogeny of Central Neural Taste Responses
David L Hill · University of Virginia · funded by National Institutes of Health
1986–2024 · research · R01
Ontogeny of Central Neural Taste Responses
Alev Erisir · University of Virginia · funded by National Institutes of Health
1986–2023 · research · R01
Ontogeny of Central Neural Taste Responses
David L Hill · University of Virginia · funded by National Institutes of Health
1985–2027 · research · R01
Molecular Mechanisms of Membrane Transport
David S Cafiso · University of Virginia · funded by National Institutes of Health
1985–2023 · training · T32
Training in the Pharmacological Sciences
Kevin R. Lynch · University of Virginia · funded by National Institutes of Health
1985–2022 · research · R01
Molecular Mechanisms of Membrane Transport
David S Cafiso · University of Virginia · funded by National Institutes of Health
1985–2027 · research · R01
Molecular Mechanisms of Membrane Transport
David S Cafiso · University of Virginia · funded by National Institutes of Health
1985–2021 · training · T32
Training in Cell and Molecular Biology
P. Todd Stukenberg · University of Virginia · funded by National Institutes of Health
1985–2023 · research · R01
Molecular Mechanisms of Membrane Transport
David S Cafiso · University of Virginia · funded by National Institutes of Health
1985–2022 · research · R01
Molecular Mechanisms of Membrane Transport
David S Cafiso · University of Virginia · funded by National Institutes of Health
1985–2023 · training · T32
Training in the Pharmacological Sciences
Kevin R. Lynch · University of Virginia · funded by National Institutes of Health
1985–2022 · research · R01
Molecular Mechanisms of Membrane Transport
David S Cafiso · University of Virginia · funded by National Institutes of Health
1985–2023 · training · T32
Training in the Pharmacological Sciences
Kevin R. Lynch · University of Virginia · funded by National Institutes of Health
1985–2021 · training · T32
Training in Cell and Molecular Biology
P. Todd Stukenberg · University of Virginia · funded by National Institutes of Health
1985–2021 · training · T32
Training in Cell and Molecular Biology
P. Todd Stukenberg · University of Virginia · funded by National Institutes of Health
1985–2023 · training · T32
Training in the Pharmacological Sciences
Kevin R. Lynch · University of Virginia · funded by National Institutes of Health
1985–2021 · training · T32
Training in Cell and Molecular Biology
P. Todd Stukenberg · University of Virginia · funded by National Institutes of Health
1985–2027 · research · R01
Molecular Mechanisms of Membrane Transport
David S Cafiso · University of Virginia · funded by National Institutes of Health
1985–2023 · training · T32
Training in the Pharmacological Sciences
Kevin R. Lynch · University of Virginia · funded by National Institutes of Health
1985–2021 · training · T32
Training in Cell and Molecular Biology
P. Todd Stukenberg · University of Virginia · funded by National Institutes of Health
1985–2022 · research · R01
Molecular Mechanisms of Membrane Transport
David S Cafiso · University of Virginia · funded by National Institutes of Health
1985–2027 · research · R01
Molecular Mechanisms of Membrane Transport
David S Cafiso · University of Virginia · funded by National Institutes of Health
1984–2028 · research · R37
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
Thomas A. Platts-Mills · University of Virginia · funded by National Institutes of Health
1984–2023 · research · R37
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
Thomas A. Platts-Mills · University of Virginia · funded by National Institutes of Health
1984–2023 · research · R37
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
Thomas A. Platts-Mills · University of Virginia · funded by National Institutes of Health
1984–2023 · research · R37
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
Thomas A. Platts-Mills · University of Virginia · funded by National Institutes of Health
1984–2028 · research · R37
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
Thomas A. Platts-Mills · University of Virginia · funded by National Institutes of Health
1984–2028 · research · R37
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
Thomas A. Platts-Mills · University of Virginia · funded by National Institutes of Health
1984–2023 · research · R37
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
Thomas A. Platts-Mills · University of Virginia · funded by National Institutes of Health
1984–2028 · research · R37
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
Thomas A. Platts-Mills · University of Virginia · funded by National Institutes of Health
1984–2023 · research · R37
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
Thomas A. Platts-Mills · University of Virginia · funded by National Institutes of Health
